Latecoere SACA

Avadel Pharmaceuticals (NASDAQ:AVDL) Earns Buy Rating from HC Wainwright

10 Jan 2025 09:04:14 By Buzz FX

Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at HC Wainwright

10 Jan 2025 09:04:14 By Buzz FX

Maplebear (NASDAQ:CART) Coverage Initiated by Analysts at Wells Fargo & Company

10 Jan 2025 09:04:14 By Buzz FX

Piper Sandler Initiates Coverage on Monopar Therapeutics (NASDAQ:MNPR)

10 Jan 2025 09:04:14 By Buzz FX

Phathom Pharmaceuticals' (PHAT) Buy Rating Reaffirmed at Needham & Company LLC

10 Jan 2025 09:04:14 By Buzz FX

Onsemi (NASDAQ:ON) Receives Hold Rating from Truist Financial

10 Jan 2025 09:03:15 By Buzz FX

UBS Group Upgrades Sunrun (NASDAQ:RUN) to "Buy"

10 Jan 2025 09:03:15 By Buzz FX

RCI Hospitality (NASDAQ:RICK) Receives Buy Rating from HC Wainwright

10 Jan 2025 09:03:15 By Buzz FX

BigCommerce (NASDAQ:BIGC) Stock Rating Lowered by Barclays

10 Jan 2025 09:03:15 By Buzz FX

Morgan Stanley Upgrades Gilead Sciences (NASDAQ:GILD) to "Overweight"

10 Jan 2025 09:03:15 By Buzz FX

Northland Securities Boosts Bitdeer Technologies Group (NASDAQ:BTDR) Price Target to $24.00

10 Jan 2025 09:03:15 By Buzz FX

Cytokinetics (NASDAQ:CYTK) Receives Buy Rating from HC Wainwright

10 Jan 2025 09:03:15 By Buzz FX

Lululemon Athletica (NASDAQ:LULU) Upgraded by Needham & Company LLC to Buy Rating

10 Jan 2025 09:03:15 By Buzz FX

CSX (NASDAQ:CSX) Stock Rating Upgraded by Jefferies Financial Group

10 Jan 2025 09:03:15 By Buzz FX

C.H. Robinson Worldwide (NASDAQ:CHRW) Rating Increased to Outperform at Raymond James

10 Jan 2025 09:03:15 By Buzz FX

Mizuho Issues Pessimistic Forecast for Simply Good Foods (NASDAQ:SMPL) Stock Price

10 Jan 2025 09:03:15 By Buzz FX

News (NASDAQ:NWSA) Now Covered by Analysts at Citigroup

10 Jan 2025 09:03:15 By Buzz FX

B. Riley Initiates Coverage on Eton Pharmaceuticals (NASDAQ:ETON)

10 Jan 2025 09:03:15 By Buzz FX

Privia Health Group (NASDAQ:PRVA) Earns Buy Rating from Analysts at Needham & Company LLC

10 Jan 2025 09:03:15 By Buzz FX

Esperion Therapeutics' (ESPR) "Buy" Rating Reiterated at HC Wainwright

10 Jan 2025 09:03:15 By Buzz FX